TOKYO -- Japan's health ministry is working to approve at-home use of the COVID-19 antibody cocktail available to inpatients, as the country's surge in new cases forces many hospitals to reserve beds only for the sickest.
Coronavirus
Japan eyes COVID antibody cocktail for homebound patients
Health ministry weighs care options outside hospitals amid bed shortage
The antibody treatment developed by U.S. company Regeneron was used to treat former President Trump. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Coronavirus
